Executive Summary
The contempt petition was filed by Pfizer Products Inc alleging non-compliance with a previous court order. The respondent submitted an affidavit stating that they had applied to the DCGI for permission to manufacture and market the new drug, Tofacitinib, under New Drugs and Clinical Trial Rules, 2019. They undertook not to commercialize the product until the patent expiry date.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Pfizer Products Inc vs D Rawal is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Hero Investcorp Pvt Ltd And AnrvsAshok Kumar (John Doe)
The Delhi High Court granted interim relief to Hero Investcorp Pvt Ltd in its suit against an unidentified entity manufacturing and selling counterfeit two-wheeler spare parts. The court recognized the Plaintiffs' registered trademarks and trade dress associated with 'HERO GENUINE PRODUCTS.' Crucially, the court appointed a Local Commissioner to execute a search and seizure commission at the Defendant's premises to recover infringing goods, setting the stage for further litigation.
Rajeshbhai Gokulbhai SojitravsRegistrar Of Trade Marks Boudhik Sampada Bhavan
The Gujarat High Court addressed a petition filed by Rajeshbhai Gokulbhai Sojitra concerning the prolonged delay in deciding his trade mark registration application for 'Krinal Double Filter Chuno'. The petitioner alleged inaction by the Registrar of Trade Marks, noting that the application had been pending since 2008. Recognizing the administrative lapse, the Court issued a directive to the Respondent Authority to finalize the decision on Application No.1688346 within eight weeks from the date of the order, without examining the merits of the underlying trade mark dispute.
Hero Investcorp Private Limited & Anr.vsM/S Limra Auto Connect
The Delhi High Court granted an ad-interim injunction in favor of Hero Investcorp Private Limited, affirming the strength of its trademark rights over 'HERO' across various products. The court also allowed the plaintiffs to proceed without mandatory pre-litigation mediation and exempted them from serving advance notice on the defendant, M/S Limra Auto Connect. Furthermore, a Local Commissioner was appointed to conduct an inventory of alleged infringing goods, including packaging materials, ensuring the preservation of evidence in this ongoing intellectual property dispute.
Natco Pharma LimitvsNovo Nordisk A/S And Ors.
The petitioner, Natco Pharma Limit, filed a petition seeking the revocation of Indian Patent No. 262697 before the Delhi High Court. The court issued notice to the respondents and directed them to file replies within six weeks.
Qualcomm IncorporatedvsThe Controller of Patents
Qualcomm appealed an order from the Patent Controller rejecting its invention titled 'ENHANCED BLOCK-REQUEST STREAMING SYSTEM FOR HANDLING LOW-LATENCY STREAMING'. The appeal argued that the Controller failed to adequately consider the appellant's written submissions and did not correctly assess the novelty and inventive step against prior art. The High Court allowed the appeal and remanded the matter for fresh consideration.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.